14 Jul 2015 07:00
Collagen Solutions Plc
(the "Company" or the "Group")
Partnership with UCL and Oxford MEStar Ltd in grant funded project
Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, announces that it is part of a consortium that has been awarded an Arthritis Research UK (ARUK) Point of Care grant to develop novel functionally man-made osteochondral scaffold for large osteochondral defect repairs. Osteochondral injury refers to repetitive trauma within a joint such as the knee or elbow.
Collagen will collaborate with UCL and Oxford MEStar, a rapidly growing company specialising in translational and regenerative medicine.
Successful delivery of this programme will lead to the development of a novel scaffold that can be used clinically in a one-step surgical procedure for treatment of large osteochondral defects. As a result, the quality of life of individuals with these defects, which often lead to osteoarthritis, will be improved allowing a pain free, more active lifestyle.
Stewart White, CEO of Collagen Solutions commented: "Our relationship with UCL has already led to the licensing of novel collagen material from the laboratories of Professor Brown. This new grant widens our collaboration with the University and will lead to the development of another collagen based, high value added product which fits in with our strategy of releasing the embedded functionality of our medical grade collagen through the development and commercialization of high value added novel products."
Enquiries:
Collagen Solutions Plc |
|
Stewart White, CEO | Tel: 0141 558 2008 |
|
|
Panmure Gordon & Co (Joint Broker) Robert Naylor (Corporate Finance) Maisie Atkinson (Corporate Broking) |
Tel: 0207 8862 714Tel: 020 7886 2905 |
|
|
Walbrook PR Ltd | Tel: 020 7933 8780 or collagen@walbrookpr.com |
Anna Dunphy | Mob: 07876 741 001 |
Mike Wort | Mob: 07900 608 002 |
About UCL (University College London)
UCL was founded in 1826. We were the first English university established after Oxford and Cambridge, the first to open up university education to those previously excluded from it, and the first to provide systematic teaching of law, architecture and medicine. We are among the world's top universities, as reflected by performance in a range of international rankings and tables. UCL currently has over 35,000 students from 150 countries and over 11,000 staff. Our annual income is more than £1 billion. www.ucl.ac.uk | Follow us on Twitter @uclnews | Watch our YouTube channel YouTube.com/UCLTV